Guideline-directed drug interventions for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: an overview of systematic reviews
Détails
ID Serval
serval:BIB_252B3D518331
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Guideline-directed drug interventions for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: an overview of systematic reviews
Périodique
Prospero : International prospective register of systematic reviews
ISSN
1358-6785
Statut éditorial
Publié
Date de publication
2017
Pages
4
Langue
anglais
Résumé
Review question(s) : Which guideline-directed drug therapy shows efficacy or inefficacy for sudden cardiac death prevention in heart failure patients with reduced ejection fraction?
Whether beta-blockers (BBs), angiotensin converting enzyme inhibitors (ACIs), angiotensin receptor blockers (ARBs), anti-aldosterone antagonists or mineralocorticoid-receptor antagonists, amiodarone, antiarrhythmics, LCZ696, statins and fish oil supplementation are effective or not in sudden cardiac death and all-cause mortality reduction?
Whether beta-blockers (BBs), angiotensin converting enzyme inhibitors (ACIs), angiotensin receptor blockers (ARBs), anti-aldosterone antagonists or mineralocorticoid-receptor antagonists, amiodarone, antiarrhythmics, LCZ696, statins and fish oil supplementation are effective or not in sudden cardiac death and all-cause mortality reduction?
Site de l'éditeur
Création de la notice
13/07/2017 14:28
Dernière modification de la notice
20/08/2019 13:03
Données d'usage
